Agilent Technologies Inc (NYSE:A) shares climbed 19% on Thursday after the company posted stronger-than-expected fiscal ...

Agilent Technologies (NYSE:A) raised its fiscal 2026 outlook after reporting stronger-than-expected second-quarter results, ...

Simon May - Senior VP and President of Life Sciences & Diagnostics Markets Group Mike Zhang - Senior VP & President of Applied Markets Group Thank you, Karina, and welcome, everyone, to Agilent's ...

What Happened? Shares of life sciences tools company Agilent Technologies (NYSE:A) jumped 16.1% in the morning session after ...

Seamless integration in current infrastructure and smooth method transfer from legacy equipment—for non-disruptive transition to highest productivity and lowest cost of ownership. The InfinityLab ...

The Agilent 6400 Series Triple Quadrupole LC/MS Systems are the proven choice for your quantitative applications in pharmaceutical ADME/DMPK studies, biomarker validation, clinical research, food ...

The Life Sciences and Diagnostics Markets Group brought in revenue of $732 million compared to $654 million a year ago.

Agilent Q2 2026 earnings call insights: revenue, margin expansion, EPS beat and raised FY26 guidance, plus China/tariff risks and pricing power.

Agilent Technologies Inc. (NYSE: A) today announced the release of a new multi-attribute method (MAM) workflow designed to help pharmaceutical and biopharmaceutical quality control (QC) laboratories ...

Agilent Technologies Inc. (NYSE: A) today announced the launch of the new 8890B GC and 8860B GC with GC Assist. GC Assist is the new, advanced instrument intelligence that provides system monitoring, ...

HPLC and LC-MS, highlighting how each technique addresses the increasingly complex analytical landscape. The session will ...